Drug Discovery & Development
Category VIEW ALL
Engineering of assembloid culture for an integrated 3D tissue formation
Technology No. 2025-PARK-71242
Small molecule anti-bacterials to treat Neisseria gonorrhoeae Infections
Technology No. 2020-RAMA-68860
Evaluation of beta/gamma-disubstituted alpha-methylene esters and lactones vs MRSA infection
Technology No. 2020-RAMA-68859
Evaluation of Alpha-methylene and Alpha-aminomethyllactones, Lactams, and Related Analogs against C. difficile
Technology No. 2018-RAMA-68247
Novel Adenoviral Vector System for Gene Delivery
Technology No. 2018-MITT-68142
Synthetic Mimics of Malonyl-CoA as Fatty Acid Synthase Inhibitors
Technology No. 2017-LOHM-67912
SHG Microscopy to Guide Targeted Measurements by Raman Spectroscopy and Synchrotron X-ray Diffraction
Technology No. 2015-SIMP-66994
Development of Degradation Resistant Peptide Based Biosensors for the Selective Measurement of Kinase Activity
Technology No. 2014-PARK-66869
Using Peptide-based Novel Biosensors to Detect Anaplastic Lymphoma Kinase Activity by Sensitization of Terbium Luminescence
Technology No. 2014-PARK-66791
Metabolite Biomarkers for Identifying Liver Cancer Patients
Technology No. 66231
Microfluid Platform to Screen Cancer Drug for Delivery
Technology No. 66164
Use of an MK2 Inhibitor to Enhance Nerve Regeneration
Technology No. 65383
Peptide Inhibitors of MAPKAP Kinase II and Methods of Use
Technology No. 64887
Mouse Monoclonal Antibodies Direct Against Mist 1
Technology No. 64058
Tetrahydro-6H-5-oxa-7-azabenzo(c)phenanthrenes as dopamine agonists
Technology No. 64153
Chromeno[4,3,2-de]isoquinolines as Potent Dopamine Receptor Ligands
Technology No. 99031
Acid Reflux Induced Laryngospasm as a Potential Mechanism of Sudden Death in Epilepsy
Technology No. 2018-IRAZ-68275
Transgenically Modified ApoE KO Rats
Technology No. 2013-GOER-66479
Abl Kinase Phosphorylation in Living Cells
Technology No. 2013-IRUD-66358
Pharmaceutical Based Recovery of Function In Chronic Spinal Cord Injury
Technology No. 61133
Enhanced Sorbose Selectivity from Glucose Isomerization on Lewis Acid Zeolites by Adjusting Confinement
Technology No. 2019-GOUN-68380
Array-to-Array Transfer with Associated Chemical Transformation
Technology No. 2023-COOK-70077
A New Molecular Representation for Deep Learning of Molecular Properties Prediction and De Novo Design
Technology No. 2023-LI-69995
Precision Nanostructured Presentation of Glycans at Interfaces for Multivalent Binding Specificity
Technology No. 2022-CLAR-69745
Deterministic Culturing of Single Cells in 3D
Technology No. 2020-SAVR-69076
Accelerated Microdroplet Synthesis of Benzimidazoles
Technology No. 2020-COOK-69066
High-throughput Label-free Enzymatic Bioassays using Automated DESI-MS
Technology No. 2020-COOK-69031
Scaled-up Microdroplet Organic Synthesis with Solvent Recycling
Technology No. 2020-COOK-68885
CHemical Reaction Integrated System (CHRIS)
Technology No. 2020-SOBR-68858
Multiplexed Inductive Nanoelectrospray Ionization Mass Spectrometry System
Technology No. 2018-COOK-68329
Accelerated Degradation of Pharmaceuticals and Related Chemical Processes
Technology No. 2018-COOK-68124
Electrophoretic Spray Mass Spectrometry
Technology No. 2017-COOK-67948
Determination of Isoaspartate in a Peptide
Technology No. 2017-COOK-67947
Combination of Cholesterol Esterification Inhibitors with Existing Therapies for Cancer Treatment
Technology No. 2017-CHEN-67647
Dual Frequency Ion Isolation in Quadrupole Ion Traps
Technology No. 2016-COOK-67503
Online Quantitative Monitoring of a Reacting Mixture
Technology No. 2016-COOK-67357
Reference-free Spatial Heterodyne Detection of Intracellular Dynamics
Technology No. 2020-NOLT-68887
Amine-boranes as bifunctional reagents for direct amidation of carboxylic acids
Technology No. 2020-RAMA-68861
Fourier Transform Fluorescence Recovery after Photobleaching (FT-FRAP) with Patterned Illumination
Technology No. 2020-SIMP-68794
Novel compositions for treating colitis and/or preventing colon cancer
Technology No. 2019-JIAN-68598
Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Triple Negative Breast Cancer Cells
Technology No. 2018-ISAA-68156
A Dock Derived Compound against Laminin Receptor (37 LR) for Anti-tumor Treatment
Technology No. 2017-FIGU-67894
Long-Chain Carboxychromanols and Analogs are Anti-Inflammatories
Technology No. 64885
Rapid plant protein extraction
Technology No. 2025-CHEN-71029
Chlorin Conjugates for Photodynamic Chemotherapy for Triple-Negative Breast Cancer
Technology No. 2023-ISAA-70121
Development of a novel cytokine-like Propeptide gene therapy platform
Technology No. 2023-FIGU-70017
Fluorescence-based Assay for Novel E3 Ligase Ligand Identification
Technology No. 2023-DAS-69989
Computational method for predicting protein function
Technology No. 2020-KIHA-68982
Fluorescent Assay for Determining Phosphoribosyl Ubiquitination
Technology No. 2020-DAS-69098
MATERIALS AND METHODS FOR THE PRODUCTION OF PHENYLALANINE
Technology No. 2025-MORG-70934
Expressible HCV Nucleic Acid and Encoded Glycoprotein Antigens and Methods
Technology No. 2025-KUHN-71090
carbonic anhydrase leads for treatment of bacterial infections
Technology No. 2025-FLAH-71261
Scientific Bespoke Artificial Intelligence Agents Optimized for Research Goals
Technology No. 2025-CHOP-71024
Targeting Cdc14 phosphatase for anti-fungal agents
Technology No. 2024-ZHAN-70728
SHP2 Degraders for Anti-cancer Therapy
Technology No. 2024-ZHAN-70417
TC-PTP/PTPN2 Degraders for Cancer Immunotherapy
Technology No. 2024-ZHAN-70394
Engineered Polymeric Excipients for Enhancing the Stability of Protein Biologics
Technology No. 2024-WON-70668
Microwave Assisted Catalytic Amidation of Organic Amines with Carboxylic Acids
Technology No. 2024-THOM-70677
5-6-5/6 Scaffold as Selective Kinase Inhibitor Moiety with Low Activity Against Immune and Cardiovascular Anti-targets
Technology No. 2024-SINT-70378
5/6-5/6-Bisaryl Substituted with Saturated Cyclic Heterocycles as TAK1 Inhibitors
Technology No. 2024-SINT-70377
Discovery of cyclic peptide natural product inhibitors of free living amoeba
Technology No. 2024-PARK-70715
mRNA Delivered Cell-surface Targeted and Epitope-focused Glycoprotein Antigens for HCV Vaccine
Technology No. 2024-KUHN-70514
A Sperm Glycoprotein-based Contraceptive Vaccine
Technology No. 2024-HOGE-70624
Enhanced immunotherapy of "cold" solid tumors using Tumor tropic S. Typhimurium expressing anti-cancer proteins
Technology No. 2024-HE-70612
Analogs of Diphyllin
Technology No. 2024-DAVI-70723
Omics Automation using Large Language Models
Technology No. 2024-CHOP-70566
PTP1B/TC-PTP Dual Protein Degraders
Technology No. 2023-ZHAN-70087
Nanopuff: Albumin-coated siRNA-bound polydopamine nanoparticles
Technology No. 2023-YEO-70458
Combination of Phosphatidyl Serine Blockade and STING Stimulation for Cancer Immunotherapy
Technology No. 2023-YEO-70023
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
Inhibitors of Solvent Front Mutated RET Kinase
Technology No. 2023-SINT-70021
Cyclic Peptide Stimulators of the Proteasome
Technology No. 2023-PARK-70287
Software: The Utility of CDK9 Inhibitors for Restricting Bladder and Cervical Cancers in Human and Dog
Technology No. 2023-KAZE-70312
PRMT Inhibitors
Technology No. 2023-HUAN-70160
A Novel Nanoparticle Adjuvant for Cancer Vaccines
Technology No. 2023-HOGE-70112
Designing HIV-1 Protease Inhibitors Using Imatinib & Nilotinib Templates for Effective HIV/AIDS Treatment
Technology No. 2023-GHOS-70150
Bacterial Carbonic Anhydrase Inhibitors with Improved Pharmacokinetics and Efficacy
Technology No. 2023-FLAH-70278
Covalent Inhibitors as Anti-malarial Agents
Technology No. 2023-FLAH-70246
Natural Product-Inspired Molecules for Covalent Inhibition of SHP2 Tyrosine Phosphatase
Technology No. 2023-DAI-70254
Repurposing Phenol & Phosphate Anticancer Drugs as Cationic Lipid Salts in Solid Lipid Nanoparticles Focused on Etoposide
Technology No. 2023-BYRN-69951
CAR-neutrophils Produced In Vivo to Treat Cancer
Technology No. 2023-BAO-70025
Treatment of Lowe Syndrome
Technology No. 2023-AGUI-69998
Nanoparticle-based Abuse Deterrent Formulations
Technology No. 2022-YEO-69643
Immunoactive Nanocarrier of Immunogenic Cell Death Inducers
Technology No. 2022-YEO-69546
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Plasticizers to Improve Release Performance of Amorphous Solid Dispersions
Technology No. 2022-TAYL-69586
Benzamide or N-hydroxybenzamide Kinase Inhibitors Derived from Doebner-Povarov Reaction
Technology No. 2022-SINT-69859
Nicotinamide-based Compounds as Potent Inhibitors of Translational- and Transcriptional-related Kinases
Technology No. 2022-SINT-69726
Enhanced Cell-potent Peptidomimetic Inhibitors for NTMT1/2
Technology No. 2022-HUAN-69636
PROTEIN:PROTEIN INTERACTION INHIBITORS
Technology No. 2022-HU-69918
Highly Efficient and Optically Active Synthesis of Crown-THF Ligand
Technology No. 2022-GHOS-69804
Potent 2420-Class of Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69733
Potent Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69724
Design and Synthesis of bi-aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer
Technology No. 2022-DYKH-69819
Cyanide Countermeasures
Technology No. 2022-DAVI-69921
Antibiotic Discovery via BICyCLE (Biologically Inspired Chemically Created Leads)
Technology No. 2021-PARK-69383
Computational Method for Modeling Protein Assembly with More Than Two Protein Subunits
Technology No. 2021-KIHA-69437
Cell-potent and Selective Inhibitors for Nicotinamide N-methyltransferase
Technology No. 2021-HUAN-69352
COMPOUNDS FOR THE TREATMENT OF SARS
Technology No. 2021-GHOS-69511
Design and Synthesis of Novel SARS-CoV-2 3C Inhibitors
Technology No. 2021-GHOS-69510
Tris-Amide Based Novel Anti-COVID-19 Compounds
Technology No. 2021-GHOS-69492
MODIFIED Discovery of Potent anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2021-GHOS-69205
Targeting BRAT1 with Curcusone Diterpenoids and Analogs for Cancer Treatment
Technology No. 2021-DAI-69235
Novel Amination Method for Medicinally Important Compounds
Technology No. 2021-DAI-69172
Single Crystal Matrix Isolation of Biopharmaceuticals for Enhanced Stability
Technology No. 2021-CHMI-69348
Nano-composite Microparticles with Ivacaftor and Colistin
Technology No. 2020-ZHOU-68954
Quinolone-based Inhibitors of Lymphoid Tyrosine Phosphatase (PTPN22)
Technology No. 2020-ZHAN-68996
N-aryl oxamic acid based inhibitors for Mycobacterium Tuberculosis Protein Tyrosine Phosphatase B (mPTPB)
Technology No. 2020-ZHAN-68995
Griseofulvin Formulation for Therapy of Wet Macular Degeneration
Technology No. 2020-YEO-69132
Mixed Solvent Micelle Formulation Procedure
Technology No. 2020-WON-69093
Activity-Based Probes with Unnatural Amino Acids to Monitor the Proteasome in Live Cells
Technology No. 2020-TRAD-68937
Telescoped Continuous Flow Synthesis of an Alkynylnaphthyridine Anticancer Agent, HSN608
Technology No. 2020-THOM-69095
Monitoring ADME Proteins in Extracellular Vesicles for Drug Therapeutics
Technology No. 2020-TAO-69103
Cell Phone Integrated Paper Microfluidic Device for Colorimetric Multiplexed Detection of Analytical Targets
Technology No. 2020-STAN-68920
2,3-Disubstituted pyrido[3,4-b]pyrazine-containing Compounds as Kinase Inhibitors
Technology No. 2020-SINT-69073
Crystallization Method to Reduce Filtration Time of Agrochemicals
Technology No. 2020-NAGY-69085
Discovery of Potent Protease Inhibitors for Covid-19 Treatment using Specifically Designed Novel bis-amide Derivatives
Technology No. 2020-GHOS-69088
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2020-GHOS-69045
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment
Technology No. 2020-GHOS-69034
NOVEL COMPOUNDS FOR IMMUNOMODULATORY ACTIVITY
Technology No. 2020-CHOP-68949
Therapeutic Strategy by Drug Repositioning against Lowe Syndrome
Technology No. 2017-AGUI-67722
Bioresorbable materials for unobtrusive, sustained topical delivery of therapeutics
Technology No. 2020-LEE-68893
Next generation SARS-CoV-2 vaccines for emerging variants
Technology No. 2025-MITT-71007
Unique Adenoviral Vector-Based Universal Influenza Vaccine
Technology No. 2025-MITT-70855
Rhodanine Linker Compounds for Inhibiting IAPP, α‑Synuclein, and Tau Aggregation with Fluorescent Probing of IAPP Fibrils
Technology No. 2025-FORT-70836
Amide‑Linked Coumarin Scaffolds Inhibit α‑Synuclein and Tau Aggregation for Neurodegenerative Drug Leads
Technology No. 2025-FORT-70835
Vascularized Neuroimmune Organoids with Patient Brain Homogenates for Alzheimer’s Research and Drug Discovery
Technology No. 2024-XU-70690
Discovery of small molecule benzothiazole and indole derivatives tackling Tau 2N4R and α-synuclein fibrils
Technology No. 2024-FORT-70558
Inhibitor against FicD/HYPE mediated AMPylation
Technology No. 2023-MATT-70064
Enzymatic Preparation of Small, Single-Stranded DNA Circles
Technology No. 2023-MAO-70050
Nanoparticle Formulation for Selective Delivery of Drugs to Cancer Cells
Technology No. 2023-HAN-70164
Urea-based Small Molecules Inhibit the Aggregation of Human and Feline Amylin for the Treatment of Type 2 Diabetes
Technology No. 2023-FORT-70255
Dithiourea Derivatives Inhibit Alpha-synuclein Oligomer and Fibril Formation
Technology No. 2023-FORT-70200
Evaluation of symmetric aminoindole-linked triazine for a dual effect on alpha-synuclein and tau isoform 2N4R fibrillization
Technology No. 2023-FORT-70004
Discovery of 4-aminoindole Carboxamide Derivatives to Curtail Tau Isoform 2N4R Oligomer and Fibril Formation
Technology No. 2023-FORT-69967
Isothiourea Catalyzed Stereoselective Glycosylation
Technology No. 2023-AXEL-70326
PLA-PCL Microsphere Formulation to Deter Abuse of Prescription Opioids by Smoking
Technology No. 2022-SOLO-69817
Screening New Drugs for Treatng Retinitis Pigmentosa
Technology No. 2022-LEUN-69895
Ligand Directed Tyrosine Conjugation on Proteins using Imine Mannich Electrophiles
Technology No. 2022-KRUS-69838
Methods for Treating Castration-Resistant Prostate Cancer
Technology No. 2022-KIM-69751
Selective Delivery of DNA Origami Nanostructures to Cancer Cells
Technology No. 2022-CHOI-69914
Novel Approach to Induce Protection against Respiratory Viruses
Technology No. 2021-MITT-69166
Affinity Labeling of DNA-linked Ligands for High Throughput Ligand Binding Assays
Technology No. 2021-KRUS-69176
Chiral Harmonophores for Alignment Detection Microscopy
Technology No. 2026-SIMP-71296
SOLVENT-DEPENDENT PREPARATION OF AMINE-BORANES VIA WATER-MEDIATED REACTION
Technology No. 2023-RAMA-70058
METHOD FOR REDUCTION OF CARBOXYLIC ACIDS WITH AMMONIA BORANE CATALYZED BY TITANIUM TETRACHLORIDE
Technology No. 2023-RAMA-70052
Fluxification: Interfacial Solute Flux Promotes Emulsification at the Water|Oil Interface
Technology No. 2023-DICK-70036
Monotrifluoroacetoxyborane-Amine Complexes for Reductive Amination and Reduction of Imines and Enamines
Technology No. 2022-RAMA-69902
CINCH - Controlled Ice Nucleation Charge Gas Humidifier
Technology No. 2021-ALEX-69302
Continuous Mycelium-Based Drug Production Using Self-Healing Solid-State Fermentation Technology
Technology No. 2025-PORT-70916
Fungal Drug Discovery Platform based on Automated Recovery of Mycelial Exudate Compounds (MECs) in Mycoponic Bioproduction
Technology No. 2025-PORT-70929

















![Chromeno[4,3,2-de]isoquinolines as Potent Dopamine Receptor Ligands](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/14379/2/chromeno432-deisoquinolines-as-potent-dopamine-receptor-ligands-01.jpg?mtime=20251204125631)



































































![2,3-Disubstituted pyrido[3,4-b]pyrazine-containing Compounds as Kinase Inhibitors](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13207/2/23-disubstituted-pyrido34-bpyrazine-containing-compounds-as-kinase-inhibitors-01.png?mtime=20251202163126)









